Kazunori Kasama Selected Research

Weight Loss (Weight Reduction)

1/2023	Best practice approach for redo-surgeries after sleeve gastrectomy, an expert's modified Delphi consensus.
1/2022	Reference Values for Weight Loss During 1 Year After Sleeve Gastrectomy: a Multicenter Retrospective Study in Japan.
7/2021	Background characteristics and diabetes remission after laparoscopic sleeve gastrectomy in Japanese patients with type 2 diabetes stratified by BMI: subgroup analysis of J-SMART.
7/2021	Endoscopic intragastric balloon therapy for 15 years in Japan: Results of nationwide surveys.
1/2021	Impact of the Hepatic Branch of the Vagus Nerve Transection in Laparoscopic Sleeve Gastrectomy for Patients with Obesity and Type 2 Diabetes Mellitus.
1/2020	Revisional Bariatric Surgery for Insufficient Weight Loss and Gastroesophageal Reflux Disease: Our 12-Year Experience.
11/2019	Background characteristics and postoperative outcomes of insufficient weight loss after laparoscopic sleeve gastrectomy in Japanese patients.
4/2019	Portomesenteric vein thrombosis after laparoscopic sleeve gastrectomy in patient with liver cirrhosis.
4/2019	Correction to: Preoperative Weight Loss and Operative Outcome After Laparoscopic Sleeve Gastrectomy.
1/2019	Influence of Asian Ethnicities on Short- and Mid-term Outcomes Following Laparoscopic Sleeve Gastrectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazunori Kasama Research Topics

Disease

20	Obesity 02/2024 - 10/2010
19	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2012
19	Weight Loss (Weight Reduction) 01/2023 - 10/2009
16	Morbid Obesity 09/2023 - 09/2007
6	Non-alcoholic Fatty Liver Disease 02/2024 - 01/2008
5	Gastroesophageal Reflux (GERD) 01/2023 - 01/2016
5	Body Weight (Weight, Body) 01/2021 - 12/2007
5	Stomach Neoplasms (Stomach Cancer) 07/2019 - 01/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2024 - 05/2012
3	Insulin Resistance 01/2019 - 03/2016
3	Neoplasms (Cancer) 01/2017 - 01/2002
2	Diabetes Mellitus 01/2022 - 11/2013
2	Overweight 01/2021 - 02/2013
2	Pathologic Constriction (Stenosis) 01/2020 - 01/2016
1	COVID-19 01/2022
1	Pediatric Obesity 01/2022
1	Liver Diseases (Liver Disease) 01/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 11/2021
1	Renal Insufficiency (Renal Failure) 11/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021
1	Hiatal Hernia 01/2021
1	Vagus Nerve Injuries 01/2021
1	Hypertension (High Blood Pressure) 11/2020
1	Dyslipidemias (Dyslipidemia) 11/2020
1	Obstructive Sleep Apnea 11/2020
1	Peptic Esophagitis (Reflux Esophagitis) 06/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Hemorrhage 10/2019
1	Thrombosis (Thrombus) 04/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2019
1	Pregnancy Complications 01/2019
1	Lower Urinary Tract Symptoms 01/2019
1	Anemia 01/2019
1	Alcoholic Fatty Liver 01/2019
1	Birth Weight (Birth Weights) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 08/2018
1	Metabolic Diseases (Metabolic Disease) 06/2018
1	Disease Progression 01/2018
1	Chronic Renal Insufficiency 01/2018
1	Proteinuria 01/2018
1	Infections 01/2017
1	Situs Inversus 08/2016
1	Dumping Syndrome (Syndrome, Dumping) 01/2016
1	Mucinous Cystadenoma 01/2002

Drug/Important Bio-Agent (IBA)

3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 01/2018
3	C-PeptideIBA 07/2021 - 03/2016
2	immunoglobulin BIBA 02/2024 - 07/2021
2	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 03/2016
2	Proton Pump InhibitorsIBA 01/2022 - 01/2020
2	Insulin (Novolin)FDA Link 07/2021 - 03/2016
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2020 - 03/2016
2	AlbuminsIBA 01/2019 - 12/2018
2	Alanine Transaminase (SGPT)IBA 12/2018 - 03/2016
1	Transaminases (Aminotransferases)IBA 02/2024
1	CholesterolIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Dihydrotachysterol (AT 10)IBA 07/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 07/2021
1	MicronutrientsIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Uric Acid (Urate)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	HDL CholesterolIBA 01/2019
1	Guanosine Triphosphate (GTP)IBA 01/2019
1	C-Reactive ProteinIBA 12/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2018
1	Antihypertensive Agents (Antihypertensives)IBA 01/2018
1	2,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dioneIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2017
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 03/2016
1	Hemoglobins (Hemoglobin)IBA 03/2016
1	Saline SolutionIBA 03/2015
1	GhrelinIBA 12/2013
1	bofu-tsusho-sanIBA 01/2012
1	Mazindol (Mazanor)FDA Link 01/2012
1	AdipokinesIBA 10/2009
1	IncretinsIBA 10/2009
1	A-factor (Streptomyces)IBA 01/2006

Therapy/Procedure

35	Bariatric Surgery 02/2024 - 11/2008
24	Gastrectomy 01/2023 - 10/2009
13	Gastric Bypass (Roux-en-Y Gastric Bypass) 02/2024 - 09/2007
6	Glycemic Control 01/2022 - 01/2017
2	Therapeutics 01/2022 - 01/2020
2	Reoperation 01/2020 - 01/2016
2	Surgical Instruments (Clip) 10/2019 - 08/2016
1	Gastric Balloon 02/2024
1	Operative Surgical Procedures 02/2024
1	Gastroplasty (Vertical-Banded Gastroplasty) 02/2024
1	Fundoplication 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Laparotomy 11/2021
1	Vagotomy 01/2021
1	Biliopancreatic Diversion 01/2020
1	Conversion to Open Surgery 10/2019
1	Preoperative Care 01/2017
1	Operative Time 08/2016
1	Diet Therapy (Therapy, Diet) 01/2012
1	Splenectomy 01/2002
1	Pancreatectomy 01/2002